Matt Belvedere is a veteran journalist at the intersection of where live television news programs and the Internet meet—developing and managing an online and social media presence for CNBC's flagship morning show, "Squawk Box."
Following years of cable and major market live TV news production, Belvedere started in 2007 the award-winning video department at usnews.com, the website of U.S. News & World Report. He also managed online strategies there at a time when the magazine was transitioning to a digital first organization.
Belvedere was nominated for a local Emmy as the Producer of morning ratings leader "News4 Today" at WRC, the NBC-owned station in Washington, D.C.
Prior to WRC, he started his career in TV production at CNBC, where he returned in the fall of 2011 as a producer on "Street Signs," before joining the digital team.
—Follow Matt Belvedere on Twitter @Matt_Belvedere
At Theranos, it was "one layer of an onion, after another, after another, after another," says Nick Bilton, special correspondent for Vanity Fair.
Former Dallas Fed President Richard Fisher tells CNBC: "I don't think I have much of a choice here.
It's time to reduce the amount of physical cash floating around the globe to help combat tax evasion and other illicit activities, renowned economist Ken Rogoff tells CNBC.
Mylan's EpiPen price hike is just the latest in a series of "poor management" decisions by the board, NYC Comptroller Scott Stringer tells CNBC.
Wells Capital Management chief strategist Jim Paulsen makes a case for why a Fed rate hike should be a positive for the stock market.
U.S. stock futures were higher this morning, ahead of the 8:30 a.m. ET release of the government's August employment report.
Hillary Clinton released a plan to combat drug price hikes, following the latest outcry over Mylan's nearly 400 percent price increase for EpiPens.
The new space race should rely more heavily on private companies than government resources, moon walker Buzz Aldrin tells CNBC.
Salesforce CEO Marc Benioff explains on "Mad Money" the company's forward guidance warning. And Cramer says Benioff deserves the benefit of the doubt.